Drawing for ANTIDOTE

USPTO serial 87043779

ANTIDOTE

Reviewed by CopyMark Law Group

Reg. 5324898Status 702Renewal
Filing date
Status date
Registration date
Oct 31, 2017
Examiner
MARSH, BRANDON N
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ANTIDOTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
035Recruiting subjects for clinical healthcare trialsACTIVESep 19, 2016
042Software as a service (SaaS) services, namely, hosting software for use by others for use in database management and patient referrals for clinical trials; providing temporary use of online nondownloadable computer software for management of clinical trials, measuring and monitoring the performance of clinical trials, for identifying and recruiting patients for participation in clinical trials, and for matching patients with clinical trials; providing medical and scientific research information in the field of clinical trials; providing the service of matching individuals with clinical trials; providing clinical trial data and patient data, and analysis of such data, all for use in clinical trial planning and recruitment of patients for clinical trials, and for pharmaceutical development; cloud computing featuring software for use in analyzing clinical trial data and patient data in connection with medical and scientific research, clinical trial planning and pharmaceutical development; providing internet search engines; providing a website featuring a search engine that enables patients to discover, connect with and participate in clinical trials; providing a website featuring medical and scientific research information related to clinical trials for the treatment of various conditionsACTIVESep 19, 2016
044Providing a website featuring health and health care information for patients seeking medical treatment through participation in clinical trialsACTIVESep 19, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 17, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 17, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 22, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jun 30, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 30, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 30, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 5, 2023WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Jan 5, 2023WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Jan 3, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 3, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 3, 2023EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Jan 3, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 3, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 3, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 31, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 31, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 27, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 27, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 27, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 26, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 26, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Sep 26, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 26, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 26, 2017SNEASU-EXAMINER'S AMENDMENT WRITTEN—
Feb 26, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2017CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2017DOCKASSIGNED TO EXAMINER—
Dec 29, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 29, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 14, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 6, 2016IUAFUSE AMENDMENT FILED—
Dec 6, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 6, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 11, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 11, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 21, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 3, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2016DOCKASSIGNED TO EXAMINER—
May 25, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance